-
Mashup Score: 16MDS Sessions: Novel agents being explored in lower- and higher-risk MDS: updates from ASH 2023 and beyond | VJHemOnc - 1 month(s) ago
Welcome to The MDS Sessions brought to you by the Video Journal of Hematology and Hematological Oncology (VJHemOnc). This exclusive discussion features leading experts Amer Zeidan, Jan Bewersdorf, Maximilian Stahl, Yasmin Abaza, and Yazan Madanat, who discuss novel agents being explored in LR- and HR-MDS.
Source: www.vjhemonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 16MDS Sessions: Novel agents being explored in lower- and higher-risk MDS: updates from ASH 2023 and beyond | VJHemOnc - 2 month(s) ago
Welcome to The MDS Sessions brought to you by the Video Journal of Hematology and Hematological Oncology (VJHemOnc). This exclusive discussion features leading experts Amer Zeidan, Jan Bewersdorf, Maximilian Stahl, Yasmin Abaza, and Yazan Madanat, who discuss novel agents being explored in LR- and HR-MDS.
Source: www.vjhemonc.comCategories: General Medicine News, Onc News and JournalsTweet-
We're so pleased to share our latest MDS session, chaired by @Dr_AmerZeidan, ft. Jan Bewersdorf, @yasminabaza1, @MaxStahlMD & @madanatyazan, who discuss: - Novel agents in LR-MDS - Novel agents in HR-MDS - Challenges in HR-MDS & more! 👉 https://t.co/GhBV4S9eYQ #MDSsm #HemOnc https://t.co/H8a1zlC0nu
-
We're so pleased to share our latest MDS session, chaired by @Dr_AmerZeidan, ft. Jan Bewersdorf, @yasminabaza1, @MaxStahlMD & @madanatyazan, who discuss: - Novel agents in LR-MDS - Novel agents in HR-MDS - Challenges in HR-MDS & more! 👉 https://t.co/GhBV4S9eYQ #MDSsm #HemOnc https://t.co/H8a1zlC0nu